Skip to content
Search

Latest Stories

Pharmacy leaders warn of 'permanent closure' in letter to Secretary of State

The trade bodies and four largest pharmacy chains in England, have jointly written to the Secretary of State for Health, Steve Barclay, warning that the sector needs urgent investment for sustainability.

The letter from AIMp, CCA, NPA, PSNC, Boots UK, Lloyds Pharmacy, Well, and Phoenix UK, warned that the 30 per cent real terms funding cuts that pharmacies have faced over the past seven years have left many businesses in a cashflow crisis.


The letter said that the government is facing a choice over the future of the country’s 11,000+ community pharmacies, with permanent closures likely and medicines supply at risk if no urgent action is taken.

“If the funding situation is not addressed, the sector is likely to move rapidly towards many permanent closures of pharmacies.”

The organisations say that once these closures start, they will be hard to stop, as the sector is now so fragile other pharmacies would struggle to pick up the slack.

On the other hand, if the Secretary of State chooses to invest in community pharmacies, they can do much to deliver cost-effective solutions for patients and the NHS more widely.

Janet Morrison, PSNC Chief Executive, said: “We have set out this picture to officials and to the pharmacy Minister, and we are pleased to have been able to work with so many others across the sector to give this united message to the Secretary of State. Government now faces a choice about community pharmacy’s future: we and the other signatories to this letter will keep working tirelessly together to ensure they make the right one. We believe that what is right for pharmacies is right for patients and right for the wider NHS.”

Dr Leyla Hannbeck, the Chief Executive of AIM, said: “Pharmacies are struggling to pay their bills. They are making losses, who can continue to survive if they are making losses? It is not just hospitals and GPs that are under pressure, it’s our pharmacies as well. We have continuously kept our doors open delivering accessible care supporting the NHS; but we are reaching a breaking point. If the Secretary of State and the NHS decision makers want that accessible care to continue to be there for vulnerable patients then they must act with urgency.”

Malcolm Harrison, the Chief Executive of the CCA said: “The sector has the potential to reduce GP waiting times and hospital re-admissions. But the decision now lies with the Secretary of State, to unlock the true potential of community pharmacies. Not investing in the sector will mean the continued erosion of service, and ultimately the permanent closure of many more community pharmacies, which will add to the already pressurized health system.”

Andrew Lane, NPA Chair, said: “We are showing the Health Secretary that we are united in our determination to take the right route – one that unlocks the full potential of community pharmacy and helps support the NHS more widely.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less